Glaukos (GKOS) stock is on pace for six straight weeks of gains and is in a buy zone. These are just a couple of reasons the glaucoma treatment specialist is Wednesday's IBD 50 Growth Stocks To Watch selection from Investor's Business Daily. Glaukos stock is rising nearly 1% on Wednesday and has gained around 34% year to date. The company…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related news